OTCMKTS:BIOAF Bioasis Technologies (BIOAF) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Bioasis Technologies Stock (OTCMKTS:BIOAF) Get Bioasis Technologies alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bioasis Technologies Inc. is a clinical-stage biotechnology company based in Vancouver, Canada, focused on advancing novel delivery technologies to transport therapeutic molecules across the blood–brain barrier (BBB). The company’s proprietary Blood–Brain Barrier Transport (BBBT) platform is designed to enable targeted delivery of peptides, proteins and enzyme replacement therapies to the central nervous system, addressing a critical challenge in treating neurological and rare lysosomal storage disorders. Bioasis’s pipeline leverages its BBBT platform to develop preclinical candidates for a range of central nervous system indications. The technology has been evaluated in multiple animal models and is engineered to improve the uptake and distribution of therapeutic payloads in brain tissue. By partnering or licensing its platform to larger pharmaceutical and biotechnology firms, Bioasis aims to accelerate the development of next-generation treatments for conditions such as Alzheimer’s disease, Parkinson’s disease and various pediatric metabolic disorders. Founded in Vancouver, Bioasis is publicly traded on the OTC Markets under the ticker symbol BIOAF. The company maintains its research and development operations in Canada and collaborates with academic institutions and industry partners to validate and expand its BBBT applications. With a focus on overcoming one of the most significant hurdles in neurotherapeutics, Bioasis strives to create new opportunities for effective brain-targeted medicines.AI Generated. May Contain Errors. Read More Receive BIOAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bioasis Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIOAF Stock News HeadlinesCanadian Investment Regulatory Organization Trading Halt - BTIMarch 21, 2024 | finance.yahoo.comBioasis Technologies Inc 107January 9, 2024 | morningstar.comMThe dollar just brokeBloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this century — and the consequences for your savings and investments could be severe. President Trump has signed executive order 14241 to initiate the first full reset of the American dollar in 50 years. A new monetary anchor is being established — one that's not gold or crypto, but something far more unexpected that Vladimir Putin once called the key to world leadership. | Porter & Company (Ad)biOasis Technologies Inc (BTI) Earnings Dates & ReportsJuly 31, 2023 | investing.comShort Volatility Alert: Bioasis Tech IncJune 27, 2023 | benzinga.comNew Haven biotech company suspending operations after failed mergerJune 22, 2023 | chron.comBioasis Technologies Inc.: Bioasis Provides Corporate Update and Announces Suspension of OperationsJune 21, 2023 | finanznachrichten.deBioasis Provides Update on Business OperationsMarch 23, 2023 | finance.yahoo.comSee More Headlines BIOAF Stock Analysis - Frequently Asked Questions How were Bioasis Technologies' earnings last quarter? Bioasis Technologies Inc. (OTCMKTS:BIOAF) released its quarterly earnings results on Wednesday, October, 27th. The company reported ($0.01) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.01). How do I buy shares of Bioasis Technologies? Shares of BIOAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings10/27/2021Today8/16/2026Fiscal Year End2/28/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:BIOAF CIKN/A Webwww.bioasis.us Phone(203) 533-7082FaxN/AEmployeesN/AYear Founded2007Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:BIOAF) was last updated on 8/16/2026 by MarketBeat.com Staff. From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredRay Dalio: Buy Gold. Get Paid.Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe Greatest Wealth Transfer Since the Internet Boom Just StartedWall Street forensic accountant Joel Litman - who flagged the 2008 crash months early and called the 2020 COVI...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioasis Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioasis Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
